APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 281 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,898,934 | -69.4% | 75,400 | -59.6% | 0.56% | -35.0% |
| Q3 2022 | $12,758,220 | +169.8% | 186,800 | +78.7% | 0.87% | +55.8% |
| Q2 2022 | $4,728,000 | -39.3% | 104,555 | -31.8% | 0.56% | +153.9% |
| Q1 2022 | $7,794,000 | -64.0% | 153,400 | -76.6% | 0.22% | -66.6% |
| Q3 2021 | $21,648,000 | +144.5% | 656,800 | +368.8% | 0.66% | +108.9% |
| Q2 2021 | $8,854,000 | +1231.4% | 140,100 | +803.9% | 0.31% | +1747.1% |
| Q1 2021 | $665,000 | -26.6% | 15,500 | -48.3% | 0.02% | -50.0% |
| Q3 2020 | $906,000 | – | 30,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |